Cempra Inc : Cempra, Inc. Reports Full Year 2011 Financial Results – 4-traders (press release)

For CEM-101, we announced positive top-line results in a Phase 2 clinical trial in community-acquired bacterial pneumonia (CABP) patients compared to levofloxacin. In 2012, we secured funding through an initial public offering to allow us to move both …

Leave a Reply

Your email address will not be published.

*